LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 79

Search options

  1. Book: Herzgruppenbetreuung in Theorie und Praxis

    Albus, Christian / Matlik, Michael / Unverdorben, Martin

    Ganzheitliche Rehabilitation bei Herz-Kreislauferkrankungen

    2014  

    Author's details Hrsg.: Michael Matlik ; Martin Unverdorben. Unter Mitarb. von Christian Albus
    Keywords Koronargruppe
    Subject Koronarclub ; Herzgruppe ; Ambulante Herzgruppe ; Ambulante Koronargruppe ; Herzsportgruppe ; Koronarsportgruppe ; Infarktsportgruppe ; Herzinfarktgruppe
    Language German
    Size 533 S. : Ill., graph. Darst.
    Publisher Spitta
    Publishing place Balingen
    Publishing country Germany
    Document type Book
    HBZ-ID HT018231000
    ISBN 978-3-941964-66-2 ; 3-941964-66-6
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Shelf markLoan statusLocation
    2014 A 1619 available for loan (reading room) Lesesaal EG

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  2. Article ; Online: Edoxaban or Vitamin K Antagonist for Atrial Fibrillation after TAVR. Reply.

    Van Mieghem, Nicolas M / Unverdorben, Martin / Dangas, George D

    The New England journal of medicine

    2022  Volume 386, Issue 8, Page(s) 804

    MeSH term(s) Anticoagulants/therapeutic use ; Atrial Fibrillation/drug therapy ; Atrial Fibrillation/surgery ; Humans ; Pyridines ; Thiazoles/therapeutic use ; Transcatheter Aortic Valve Replacement ; Vitamin K/antagonists & inhibitors
    Chemical Substances Anticoagulants ; Pyridines ; Thiazoles ; Vitamin K (12001-79-5) ; edoxaban (NDU3J18APO)
    Language English
    Publishing date 2022-02-23
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 207154-x
    ISSN 1533-4406 ; 0028-4793
    ISSN (online) 1533-4406
    ISSN 0028-4793
    DOI 10.1056/NEJMc2120127
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Ua VI Zs.34: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  3. Book: Kleines Fachlexikon kardiologischer Begriffe

    Unverdorben, Martin / Unverdorben, Susanne

    für Übungsleiter und Patienten

    2002  

    Title variant Fachlexikon kardiologischer Begriffe
    Author's details M. Unverdorben ; S. Unverdorben
    Keywords Herzkrankheit
    Subject Herzerkrankung ; Herzkrankheiten
    Language German
    Size 72 S. : Ill.
    Edition [2. überarb. Aufl.]
    Publisher Spitta
    Publishing place Balingen
    Publishing country Germany
    Document type Book
    Old title 1. Aufl. u.d.T. Unverdorben, Martin: Herz-Fachbegriffe mit Erläuterungen für Übungsleiter und Patienten
    HBZ-ID HT013537048
    ISBN 3-934211-19-4 ; 978-3-934211-19-3
    Database Catalogue ZB MED Medicine, Health

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Shelf markLoan statusLocation
    2009 A 10556 order for loan Magazin

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  4. Book: Herz-Fachbegriffe mit Erläuterungen für Übungsleiter und Patienten

    Unverdorben, Martin / Unverdorben, Susanne

    2001  

    Author's details M. Unverdorben ; S. Unverdorben
    Keywords Herzkrankheit
    Subject Herzerkrankung ; Herzkrankheiten
    Language German
    Size 68 S.
    Publisher Spitta-Verl
    Publishing place Balingen
    Publishing country Germany
    Document type Book
    New title Später u.d.T. Unverdorben, Martin: Kleines Fachlexikon kardiologischer Begriffe
    HBZ-ID HT012958958
    ISBN 3-934211-19-4 ; 978-3-934211-19-3
    Database Catalogue ZB MED Medicine, Health

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Shelf markLoan statusLocation
    2003 A 2144 order for loan Magazin

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  5. Book: Kardiologische Prävention und Rehabilitation

    Bock, Elke / Unverdorben, Martin

    Lehrbuch für Ärzte in Herzgruppen

    1995  

    Author's details M. Unverdorben ... (Hrsg.). Im Auftr. der Deutschen Gesellschaft für Prävention und Rehabilitation von Herz-Kreislauferkrankungen (DGPR). Mit Beitr. von E. Bock
    Keywords Cardiovascular Diseases / prevention & control ; Cardiovascular Diseases / rehabilitation ; Koronargruppe
    Subject Koronarclub ; Herzgruppe ; Ambulante Herzgruppe ; Ambulante Koronargruppe ; Herzsportgruppe ; Koronarsportgruppe ; Infarktsportgruppe ; Herzinfarktgruppe
    Language German
    Size 320 S. : Ill., graph. Darst.
    Publisher Dt. Ärzte-Verl
    Publishing place Köln
    Document type Book
    HBZ-ID HT006799053
    ISBN 3-7691-0297-5 ; 978-3-7691-0297-0
    Database Catalogue ZB MED Medicine, Health

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Shelf markLoan statusLocation
    1996 A 49 order for loan Magazin

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  6. Article ; Online: Predictive Factors and Clinical Events Associated with Edoxaban Interruption and Heparin Bridging Strategy: EMIT-AF/VTE.

    Santamaria, Amparo / Chen, Cathy / Colonna, Paolo / von Heymann, Christian / Saxena, Manish / Vanassche, Thomas / Jin, James / Unverdorben, Martin

    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

    2023  Volume 29, Page(s) 10760296231200223

    Abstract: Patients treated with edoxaban may require diagnostic and therapeutic procedures that involve edoxaban interruption. Although heparin bridging strategies are not recommended, heparin is frequently used in clinical practice. However, whether heparin use ... ...

    Abstract Patients treated with edoxaban may require diagnostic and therapeutic procedures that involve edoxaban interruption. Although heparin bridging strategies are not recommended, heparin is frequently used in clinical practice. However, whether heparin use decreases thromboembolic risk remains unclear, and the potential for increased periprocedural bleeding remains a concern. Here, we report factors predicting edoxaban interruption and the use of heparin bridging strategies and associated clinical events from Global EMIT-AF/VTE, a multicenter, prospective, noninterventional study (Clinicaltrials.gov NCT02950168). Eligible patients are adults with atrial fibrillation or venous thromboembolism treated with edoxaban who underwent a diagnostic or therapeutic procedure. Edoxaban interruption, heparin bridging strategies, and clinical event data were collected from 5 days before procedure through 29 days afterwards. Edoxaban was interrupted in 1222/2089 procedures (58.5%); a heparin bridging strategy was used during 178 (14.6%) of these interruptions. Patients who received periprocedural heparin had higher baseline HAS-BLED (2.4±1.0 vs 1.9±1.1,
    MeSH term(s) Humans ; Anticoagulants/adverse effects ; Atrial Fibrillation/drug therapy ; Hemorrhage/chemically induced ; Hemorrhage/diagnosis ; Heparin/adverse effects ; Prospective Studies ; Risk Factors ; Stroke/drug therapy ; Venous Thromboembolism/drug therapy
    Chemical Substances Anticoagulants ; edoxaban (NDU3J18APO) ; Heparin (9005-49-6)
    Language English
    Publishing date 2023-09-12
    Publishing country United States
    Document type Clinical Study ; Journal Article ; Multicenter Study
    ZDB-ID 1237357-6
    ISSN 1938-2723 ; 1076-0296
    ISSN (online) 1938-2723
    ISSN 1076-0296
    DOI 10.1177/10760296231200223
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 4370: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (2.OG)
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  7. Book ; Thesis: Untersuchung zur Differenzierung ischaemischer von digitalisbedingten Erregungsrueckbildungsstoerungen im Belastungs-EKG

    Unverdorben, Martin

    1982  

    Size 96 S.
    Document type Book ; Thesis
    Thesis / German Habilitation thesis Frankfurt am Main, Univ., Diss., 1982
    HBZ-ID HT002605005
    Database Catalogue ZB MED Medicine, Health

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Shelf markLoan statusLocation
    83 D 749 order for loan Magazin

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  8. Article ; Online: Outcomes after TAVI in patients with atrial fibrillation and a history of recent PCI: Results from the ENVISAGE-TAVI AF trial.

    Moreno, Raúl / Souza, José / Smolnik, Rüdiger / Nombela-Franco, Luis / Van Mieghem, Nicolas M / Hengstenberg, Christian / Valgimigli, Marco / Jin, James / Ohlmann, Patrick / Dangas, George / Unverdorben, Martin / Möllmann, Helge

    Clinical research in cardiology : official journal of the German Cardiac Society

    2024  

    Abstract: Background: Patients with atrial fibrillation (AF) and a recent (≤ 90 days) percutaneous coronary intervention (PCI) undergoing transcatheter aortic valve implantation (TAVI) are at high bleeding risk due to the addition of oral antiplatelet (OAP) ... ...

    Abstract Background: Patients with atrial fibrillation (AF) and a recent (≤ 90 days) percutaneous coronary intervention (PCI) undergoing transcatheter aortic valve implantation (TAVI) are at high bleeding risk due to the addition of oral antiplatelet (OAP) agents on top of oral anticoagulants. Data on outcomes of these patients are needed to optimize antithrombotic treatment.
    Methods: This analysis compared annualized clinical event rates in patients with and without a recent PCI enrolled in ENVISAGE-TAVI AF, a prospective, randomized, open-label, adjudicator-masked trial comparing edoxaban and vitamin K antagonists in AF patients after TAVI. The primary efficacy and safety outcomes were net adverse clinical events (NACE) and major bleeding.
    Results: Overall, 132 (94.3%) patients with a recent PCI (n = 140) received OAP after TAVI, compared with 692 (55.9%) patients without a recent PCI (n = 1237). Among patients with a recent PCI on OAP agents, use of dual antiplatelet therapy decreased to 5.5%, and use of single antiplatelet therapy (SAPT) increased to 78.0% over 3 months post-randomization. Conversely, use of SAPT predominated at all time points in patients without a recent PCI history. There were no significant differences in the incidence of NACE or other outcomes assessed, except for major bleeding events, which were more frequent in patients with vs without a recent PCI history (hazard ratio [95% confidence interval]: 2.17 [1.27, 3.73]; P = 0.005).
    Conclusions: Patients with AF undergoing TAVI with a recent PCI have a similar risk of ischemic events and mortality, but an increased risk of major bleeding compared with patients without a recent PCI.
    Language English
    Publishing date 2024-01-31
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 2213295-8
    ISSN 1861-0692 ; 1861-0684
    ISSN (online) 1861-0692
    ISSN 1861-0684
    DOI 10.1007/s00392-024-02379-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Ui IV Zs 10: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  9. Article ; Online: Prescribing Patterns and Outcomes of Edoxaban in Atrial Fibrillation Patients From Asia　- One-Year Data From the Global ETNA-AF Program.

    Choi, Jong-Il / Kiatchoosakun, Songsak / Jiampo, Panyapat / Tse, Hung Fat / Soo, Yannie Oi Yan / Wang, Chun-Chieh / Lee, Chang Hoon / Pecen, Ladislav / Unverdorben, Martin / De Caterina, Raffaele / Kirchhof, Paulus

    Circulation reports

    2024  Volume 6, Issue 3, Page(s) 86–93

    Abstract: Background: ...

    Abstract Background:
    Language English
    Publishing date 2024-02-20
    Publishing country Japan
    Document type Journal Article
    ISSN 2434-0790
    ISSN (online) 2434-0790
    DOI 10.1253/circrep.CR-23-0098
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

  10. Article: Prescribing Patterns and Outcomes of Edoxaban in Atrial Fibrillation: One-Year Data from the Global ETNA-AF Program.

    Chao, Tze-Fan / Unverdorben, Martin / Kirchhof, Paulus / Koretsune, Yukihiro / Yamashita, Takeshi / Crozier, Robert A / Pecen, Ladislav / Chen, Cathy / Borrow, Amanda P / De Caterina, Raffaele

    Journal of clinical medicine

    2023  Volume 12, Issue 5

    Abstract: Non-recommended dosing occurs in ~25-50% of non-vitamin K antagonist oral anticoagulant prescriptions, with limited data for edoxaban. We analyzed edoxaban dosing patterns in atrial fibrillation patients from the Global ETNA-AF program, relating patterns ...

    Abstract Non-recommended dosing occurs in ~25-50% of non-vitamin K antagonist oral anticoagulant prescriptions, with limited data for edoxaban. We analyzed edoxaban dosing patterns in atrial fibrillation patients from the Global ETNA-AF program, relating patterns to baseline characteristics and 1-year clinical outcomes. The following dosing groups were compared: non-recommended 60 mg ("overdosed") vs. recommended 30 mg; non-recommended 30 mg ("underdosed") vs. recommended 60 mg. Most (22,166/26,823; 82.6%) patients received recommended doses. Non-recommended dosing was more frequent near label-specified dose-reduction thresholds. Ischemic stroke (IS; HR 0.85, 95% CI 0.50-1.47;
    Language English
    Publishing date 2023-02-27
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2662592-1
    ISSN 2077-0383
    ISSN 2077-0383
    DOI 10.3390/jcm12051870
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

To top